Product Risk Warning:
Investment involves risks, including the loss of principle. Past performance is not indicative of future results. Before investing in below products, investor should refer to the Fund's prospectus for details, including the risk factors. You should not make investment decision based on the information on this material alone. Please note:
Important Information about ChinaAMC MSCI China A 50 Connect ETF
Important Information about ChinaAMC Hang Seng Hong Kong Biotech Index ETF
Important Information about ChinaAMC Hang Seng TECH Index ETF
Important Information about ChinaAMC CSI 300 Index ETF
Important Information about ChinaAMC NASDAQ 100 ETF
Important Information about ChinaAMC Asia High Dividend ETF
Important Information about ChinaAMC MSCI Japan Hedged to USD ETF
Important Information about ChinaAMC MSCI Europe Quality Hedged to USD ETF
Important Information about ChinaAMC Hong Kong Banks ETF
Important Information about ChinaAMC MSCI Asia Pacific Real Estate ETF
Important Information about ChinaAMC Asia USD Investment Grade Bond ETF
Important Information about ChinaAMC Bloomberg China Treasury + Policy Bank Bond Index ETF
Important Information about ChinaAMC NASDAQ-100 Index Daily (2x) Leveraged Product / ChinaAMC Nasdaq-100 Index Daily (-1x) Inverse Product / ChinaAMC Nasdaq-100 Index Daily (-2x) Inverse Product
Important Information about ChinaAMC CSI 300 Index Daily (2x) Leveraged Product/ChinaAMC CSI 300 Index Daily (-1x) Inverse Product (The product is a synthetic product)
China A50 Connect ETF?
Source: Wind，as of 30 Nov 2021
Source: MSCI, Bloomberg, Data are calculated from 31 Dec 2014 to 30 Nov 2021
|Top 10 constituents||Stock Code||Stock Name||Index Weighting (%)|
|1||300750||Contemporary Amperex Technology Co Ltd||10.86|
|2||600519||Kweichow Moutai Co Ltd||7.94|
|3||601012||LONGi Green Energy Technology Co Ltd||5.92|
|4||600036||China Merchants Bank Co Ltd||4.40|
|5||002475||Luxshare Precision Industry Co Ltd||3.48|
|6||002594||BYD Co Ltd||3.43|
|7||600309||Wanhua Chemical Group Co Ltd||3.37|
|8||603501||Will Semiconductor Co Ltd Shanghai||2.96|
|9||000858||Wuliangye Yibin Co Ltd||2.77|
|10||002812||Yunnan Energy New Material Co Ltd||2.53|
|Index Name||MSCI China A50 Connect Index|
|Index Launch Date||20 August 2021|
|Index Base Date||30 November 2012|
|No. of Constituents||51|
Step 1: Select two stocks with biggest index weight from each of the 11 GICS® sectors
Step 2: After Step 1, select remaining 28 stocks from the large cap universe with highest index weights, making the total number of stocks at 50
|Rebalancing Frequency||Quarterly rebalance (in Feb, May, Aug and Nov)|
|Weighting methodology||Adopt “sector neutral” approach, meaning the sector weight of the MSCI China A50 Connect Index during quarterly rebalancing is equal to its weight in the parent index (MSCI China A Index)|
|Source: MSCI, Bloomberg, as of 30 Nov 2021|
Investing involves risk, including possible loss of principal. Investment in emerging market countries may involve heightened risks such as increased volatility and lower trading volume, and may be subject to a greater risk of loss than investment in a developed country. Please carefully consider the Fund's investment objectives, risk factors, and charges and expenses before investing. This and other information can be found in the relevant Fund's prospectus. Please read the prospectus carefully before investing. ChinaAMC Funds are not sponsored, endorsed, issued, sold or promoted by their index providers (only applicable to ETFs and index funds). For details of an index provider including any disclaimer, please refer to the relevant ChinaAMC Fund offering documents.
Source: Fund performance and index data are provided by ChinaAMC and the relevant index providers (if applicable) respectively. This website is prepared by China Asset Management (Hong Kong) Limited and has not been reviewed by the Securities and Futures Commission.
MSCI Index Disclaimer
The funds or securities referred to herein are not sponsored, endorsed, or promoted by MSCI, and MSCI bears no liability with respect to any such funds or securities or any index on which such funds or securities are based. The Prospectus contains a more detailed description of the limited relationship MSCI has with China Asset Management (Hong Kong) Limited and any related funds.
CSI Index Disclaimer
All rights in the CSI 300 Index ("Index") vest in China Securities Index Company ("CSI"). "CSI 300®" is a trade mark of CSI. CSI does not make any warranties, express or implied, regarding the accuracy or completeness of any data related to the Index. CSI is not liable to any person for any error of the Index (whether due to negligence or otherwise), nor shall it be under any obligation to advise any person of any error therein. The Fund based on the Index is in no way sponsored, endorsed, sold or promoted by CSI and CSI shall not have any liability with respect thereto.
Bloomberg Index Disclaimer
“Bloomberg®”, Bloomberg Asia USD Investment Grade Bond Index and Bloomberg China Treasury + Policy Bank Index are service marks of Bloomberg Finance L.P. and its affiliates, including Bloomberg Index Services Limited (“BISL”), the administrator of the index (collectively, “Bloomberg”) and have been licensed for use for certain purposes by China Asset Management (Hong Kong) Limited. Bloomberg is not affiliated with China Asset Management (Hong Kong) Limited, and Bloomberg does not approve, endorse, review, or recommend ChinaAMC Asia USD Investment Grade Bond ETF and ChinaAMC Bloomberg China Treasury + Policy Bank Bond Index ETF. Bloomberg does not guarantee the timeliness, accurateness, or completeness of any data or information relating to ChinaAMC Asia USD Investment Grade Bond ETF and ChinaAMC Bloomberg China Treasury + Policy Bank Bond Index ETF.
NASDAQ Index Disclaimer
The Product(s) is not sponsored, endorsed, sold or promoted by NASDAQ, Inc. or its affiliates (NASDAQ, Inc. with its affiliates, is referred to as "NASDAQ"). NASDAQ has not passed on the legality or suitability of, or the accuracy or adequacy of descriptions and disclosures relating to, the Product. NASDAQ makes no representation or warranty, express or implied, to the owners of shares of the Product or any member of the public regarding the advisability of investing in securities generally or in the Product particularly or the ability of the Index to track general stock market performance. NASDAQ's only relationship to the Product and China Asset Management (Hong Kong) Limited ("ChinaAMC") is in the licensing of certain trademarks and trade names of NASDAQ and of the Index which is determined, composed and calculated by NASDAQ without regard to ChinaAMC or the Product. NASDAQ QMX has no obligation to take the needs of ChinaAMC or its affiliates or the owners of shares of the Product into consideration in determining, composing or calculating the Index. NASDAQ is not responsible for and has not participated in the determination of the prices and amount of shares of the Product, or the timing of the issuance or sale of such shares or in the determination or calculation of the equation by which shares of the Product are to be converted into cash. NASDAQ has no obligation or liability in connection with the administration, marketing or trading of the Product.
NASDAQ does not guarantee the accuracy and/or uninterrupted calculation of the index or any data included therein. Nasdaq makes no warranty, express or implied, as to results to be obtained by the trust on behalf of the product as licensee, licensee's customers and counterparties, owners of the shares of the product, or any other person or entity from the use of the subject index or any data included therein in connection with the rights licensed as described herein or for any other use. NASDAQ makes no express or implied warranties and hereby expressly disclaims all warranties of merchantability or fitness for a particular purpose or use with respect to the index or any data included therein. Without limiting any of the foregoing, in no event shall NASDAQ have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages.
Hang Seng Index Disclaimer
The Hang Seng Hong Kong-Listed Biotech Index and the Hang Seng TECH Index (the “Indices”) are published and compiled by Hang Seng Indexes Company Limited (“HSIL”) pursuant to a licence from Hang Seng Data Services Limited (“HSDS”). The mark and name of the Indices are proprietary to HSDS. HSIL and HSDS have agreed to the use of, and reference to, the Indices by the Manager and the Trustee and their respective duly appointed agents in connection with ChinaAMC Hang Seng Hong Kong Biotech Index ETF and ChinaAMC Hang Seng TECH Index ETF (the “Products”), BUT NEITHER HSIL NOR HSDS WARRANTS OR REPRESENTS OR GUARANTEES TO ANY BROKER OR HOLDER OF THE PRODUCTS OR ANY OTHER PERSON (i) THE ACCURACY OR COMPLETENESS OF THE INDICES AND THEIR COMPUTATION OR ANY INFORMATION RELATED THERETO; OR (ii) THE FITNESS OR SUITABILITY FOR ANY PURPOSE OF THE INDICES OR ANY COMPONENT OR DATA COMPRISED IN THEM; OR (iii) THE RESULTS WHICH MAY BE OBTAINED BY ANY PERSON FROM THE USE OF THE INDICES OR ANY COMPONENT OR DATA COMPRISED IN THEM FOR ANY PURPOSE, AND NO WARRANTY OR REPRESENTATION OR GUARANTEE OF ANY KIND WHATSOEVER RELATING TO THE INDICES ARE GIVEN OR MAY BE IMPLIED. The process and basis of computation and compilation of the Indices and any of the related formula or formulae, constituent stocks and factors may at any time be changed or altered by HSIL without notice. TO THE EXTENT PERMITTED BY APPLICABLE LAW, NO RESPONSIBILITY OR LIABILITY IS ACCEPTED BY HSIL OR HSDS (i) IN RESPECT OF THE USE OF AND/OR REFERENCE TO THE INDICES BY THE MANAGER IN CONNECTION WITH THE PRODUCTS; OR (ii) FOR ANY INACCURACIES, OMISSIONS, MISTAKES OR ERRORS OF HSIL IN THE COMPUTATION OF THE INDICES; OR (iii) FOR ANY INACCURACIES, OMISSIONS, MISTAKES, ERRORS OR INCOMPLETENESS OF ANY INFORMATION USED IN CONNECTION WITH THE COMPUTATION OF THE INDICES WHICH IS SUPPLIED BY ANY OTHER PERSON; OR (iv) FOR ANY ECONOMIC OR OTHER LOSS WHICH MAY BE DIRECTLY OR INDIRECTLY SUSTAINED BY ANY BROKER OR HOLDER OF THE PRODUCTS OR ANY OTHER PERSON DEALING WITH THE PRODUCTS AS A RESULT OF ANY OF THE AFORESAID, AND NO CLAIMS, ACTIONS OR LEGAL PROCEEDINGS MAY BE BROUGHT AGAINST HSIL AND/OR HSDS in connection with the Products in any manner whatsoever by any broker, holder or any other person dealing with the Products. Any broker, holder or other person dealing with the Products does so therefore in full knowledge of this disclaimer and can place no reliance whatsoever on HSIL and HSDS. For the avoidance of doubt, this disclaimer does not create any contractual or quasi-contractual relationship between any broker, holder or other person and HSIL and/or HSDS and must not be construed to have created such relationship.